开云app官网登录入口网页版-官方正版

#病毒载体#

26篇内容 | 1509人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2207717, encodeId=ae48220e7170b, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a> <a href='/topic/show?id=86ab41e960f' target=_blank style='color:#2F92EE;'>#基因疗法#</a> <a href='/topic/show?id=92bb291106f' target=_blank style='color:#2F92EE;'>#免疫系统#</a> <a href='/topic/show?id=93d7951895b' target=_blank style='color:#2F92EE;'>#遗传疾病#</a>, objectTitle=Nature：基因疗法面临免疫系统挑战，我们如何应对？, objectType=article, longId=826381, objectId=fddb82638191, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240531/1717126213202_5579292.png, objectUrl=/article/show_article.do?id=fddb82638191, replyNumber=0, likeNumber=69, createdTime=2024-05-31, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fddb82638191, moduleTitle=Nature：基因疗法面临免疫系统挑战，我们如何应对？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fddb82638191)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1724173, encodeId=9c5c1e2417384, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=突发！强生腺病毒载体新冠疫苗因血栓风险，被FDA限制授权使用, objectType=article, longId=726293, objectId=2a50e26293e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a50e26293e8, replyNumber=0, likeNumber=115, createdTime=2022-12-08, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a50e26293e8, moduleTitle=突发！强生腺病毒载体新冠疫苗因血栓风险，被FDA限制授权使用, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2a50e26293e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724174, encodeId=5d0a1e2417413, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=Nat Biotech：一次生产10亿CAR-T细胞，新型CRISPR技术，无需病毒载体高效插入超长DNA序列, objectType=article, longId=739036, objectId=f1d8e3903613, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1d8e3903613, replyNumber=0, likeNumber=65, createdTime=2023-01-21, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1d8e3903613, moduleTitle=Nat Biotech：一次生产10亿CAR-T细胞，新型CRISPR技术，无需病毒载体高效插入超长DNA序列, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f1d8e3903613)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724172, encodeId=ed661e241723a, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=秋水仙碱可能会干扰基于腺病毒载体的 COVID-19 疫苗的功效, objectType=article, longId=302289, objectId=057330228912, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=057330228912, replyNumber=0, likeNumber=90, createdTime=2022-12-03, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=057330228912, moduleTitle=秋水仙碱可能会干扰基于腺病毒载体的 COVID-19 疫苗的功效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=057330228912)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724171, encodeId=38aa1e2417155, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=Cell重磅：刘如谦开发新型类病毒载体，安全高效进行体内基因编辑, objectType=article, longId=294244, objectId=ee7129424476, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee7129424476, replyNumber=0, likeNumber=66, createdTime=2022-10-04, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee7129424476, moduleTitle=Cell重磅：刘如谦开发新型类病毒载体，安全高效进行体内基因编辑, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ee7129424476)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724169, encodeId=3f381e2416921, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=病毒载体基因治疗CDMO引领者五加和基因完成A轮融资，凯乘资本担任独家财务顾问 , objectType=article, longId=217846, objectId=302321e84652, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=302321e84652, replyNumber=0, likeNumber=79, createdTime=2021-10-07, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=302321e84652, moduleTitle=病毒载体基因治疗CDMO引领者五加和基因完成A轮融资，凯乘资本担任独家财务顾问 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=302321e84652)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724170, encodeId=12ae1e241701f, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=2021年11月13日简报：全球首款吸入式腺病毒载体新冠疫苗克威莎亮相；欧洲多国疫情攀升，北欧多国加强控制, objectType=article, longId=220265, objectId=55d122026515, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55d122026515, replyNumber=0, likeNumber=67, createdTime=2022-02-12, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55d122026515, moduleTitle=2021年11月13日简报：全球首款吸入式腺病毒载体新冠疫苗克威莎亮相；欧洲多国疫情攀升，北欧多国加强控制, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=55d122026515)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724168, encodeId=a9631e2416882, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=2021年9月8日简报：国内接种新冠疫苗人数达10.95亿人，超21亿剂次，全国高风险区清零；灭活疫苗接种后采用腺病毒载体疫苗加强，效果可能更好；新冠变异病毒mu毒株覆盖美国全境, objectType=article, longId=216830, objectId=700c216830cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=700c216830cd, replyNumber=0, likeNumber=88, createdTime=2022-03-30, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=700c216830cd, moduleTitle=2021年9月8日简报：国内接种新冠疫苗人数达10.95亿人，超21亿剂次，全国高风险区清零；灭活疫苗接种后采用腺病毒载体疫苗加强，效果可能更好；新冠变异病毒mu毒株覆盖美国全境, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=700c216830cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724167, encodeId=c44e1e2416724, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=研究发现腺病毒载体新冠疫苗诱发血栓的机制, objectType=article, longId=213951, objectId=9a6b21395165, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a6b21395165, replyNumber=0, likeNumber=87, createdTime=2022-02-27, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a6b21395165, moduleTitle=研究发现腺病毒载体新冠疫苗诱发血栓的机制, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9a6b21395165)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724164, encodeId=06ef1e2416440, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=专家解读腺病毒载体疫苗：单针接种加快构建免疫屏障, objectType=article, longId=208028, objectId=eb0920802840, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb0920802840, replyNumber=0, likeNumber=80, createdTime=2021-10-25, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb0920802840, moduleTitle=专家解读腺病毒载体疫苗：单针接种加快构建免疫屏障, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=eb0920802840)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724165, encodeId=211a1e2416591, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=强生疫苗或导致血栓，腺病毒载体疫苗还安全吗？, objectType=article, longId=209838, objectId=60f620983808, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60f620983808, replyNumber=0, likeNumber=85, createdTime=2022-03-11, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60f620983808, moduleTitle=强生疫苗或导致血栓，腺病毒载体疫苗还安全吗？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=60f620983808)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724162, encodeId=e0a71e24162bf, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=The Lancet：阿斯利康黑猩猩型腺病毒载体COVID-19疫苗在老年人中诱导了强烈的免疫应答, objectType=article, longId=203564, objectId=e98a203564e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e98a203564e4, replyNumber=0, likeNumber=96, createdTime=2021-09-25, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e98a203564e4, moduleTitle=The Lancet：阿斯利康黑猩猩型腺病毒载体COVID-19疫苗在老年人中诱导了强烈的免疫应答, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e98a203564e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724166, encodeId=2f651e2416645, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=新冠疫苗前沿知识：mRNA疫苗、重组蛋白疫苗、腺病毒载体疫苗, objectType=article, longId=212051, objectId=95b6212051bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95b6212051bf, replyNumber=0, likeNumber=92, createdTime=2021-07-10, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95b6212051bf, moduleTitle=新冠疫苗前沿知识：mRNA疫苗、重组蛋白疫苗、腺病毒载体疫苗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=95b6212051bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724161, encodeId=6c711e24161c3, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=万泰生物「鼻喷流感病毒载体新冠肺炎疫苗」启动 I 期临床试验, objectType=article, longId=200517, objectId=359220051e83, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=359220051e83, replyNumber=0, likeNumber=68, createdTime=2020-11-07, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=359220051e83, moduleTitle=万泰生物「鼻喷流感病毒载体新冠肺炎疫苗」启动 I 期临床试验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=359220051e83)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724160, encodeId=5c711e2416054, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=GMP级慢病毒载体制备CAR-T细胞治疗之进展及未来, objectType=article, longId=199863, objectId=fd06199863f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd06199863f5, replyNumber=0, likeNumber=79, createdTime=2021-04-23, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd06199863f5, moduleTitle=GMP级慢病毒载体制备CAR-T细胞治疗之进展及未来, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fd06199863f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724163, encodeId=32c71e24163d5, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=NEJM: 强生公布腺病毒载体新冠疫苗Ad26.COV2.S早期临床结果，效果惊人, objectType=article, longId=205806, objectId=d2be20580664, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2be20580664, replyNumber=0, likeNumber=91, createdTime=2021-04-30, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2be20580664, moduleTitle=NEJM: 强生公布腺病毒载体新冠疫苗Ad26.COV2.S早期临床结果，效果惊人, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d2be20580664)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724159, encodeId=b0b11e24159c4, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=国内首家非病毒载体CAR-T细胞治疗产品获批临床, objectType=article, longId=164209, objectId=53ae164209ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53ae164209ad, replyNumber=0, likeNumber=77, createdTime=2019-12-03, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53ae164209ad, moduleTitle=国内首家非病毒载体CAR-T细胞治疗产品获批临床, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=53ae164209ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724158, encodeId=3d381e24158cb, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=Emerging Mic Infect：广州生物院研制出新型腺病毒载体埃博拉疫苗, objectType=article, longId=140224, objectId=47bb14022490, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47bb14022490, replyNumber=0, likeNumber=80, createdTime=2019-03-06, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47bb14022490, moduleTitle=Emerging Mic Infect：广州生物院研制出新型腺病毒载体埃博拉疫苗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=47bb14022490)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724157, encodeId=e2d51e241573a, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=Lancet Child Adol Health：AADC基因腺病毒载体基因治疗用于芳香族氨基酸脱羧酶缺乏, objectType=article, longId=117384, objectId=d95c11e38499, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d95c11e38499, replyNumber=0, likeNumber=79, createdTime=2018-09-03, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d95c11e38499, moduleTitle=Lancet Child Adol Health：AADC基因腺病毒载体基因治疗用于芳香族氨基酸脱羧酶缺乏, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d95c11e38499)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1724156, encodeId=42151e241565f, content=<a href='/topic/show?id=f9cfe09905f' target=_blank style='color:#2F92EE;'>#病毒载体#</a>, objectTitle=N Engl J Med：黑猩猩腺病毒载体埃博拉疫苗, objectType=article, longId=91378, objectId=1170913e87c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1170913e87c, replyNumber=0, likeNumber=84, createdTime=2017-08-22, rootId=0, userName=ewsr12, userId=ebd533571600, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1170913e87c, moduleTitle=N Engl J Med：黑猩猩腺病毒载体埃博拉疫苗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1170913e87c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

病毒载体

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#病毒载体# #基因疗法# #免疫系统# #遗传疾病#

Nature：基因疗法面临免疫系统挑战，我们如何应对？

2024-05-31发表于上海

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

突发！强生腺病毒载体新冠疫苗因血栓风险，被FDA限制授权使用

2022-12-08

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

Nat Biotech：一次生产10亿CAR-T细胞，新型CRISPR技术，无需病毒载体高效插入超长DNA序列

2023-01-21

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

秋水仙碱可能会干扰基于腺病毒载体的 COVID-19 疫苗的功效

2022-12-03

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

Cell重磅：刘如谦开发新型类病毒载体，安全高效进行体内基因编辑

2022-10-04

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

病毒载体基因治疗CDMO引领者五加和基因完成A轮融资，凯乘资本担任独家财务顾问

2021-10-07

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

2021年11月13日简报：全球首款吸入式腺病毒载体新冠疫苗克威莎亮相；欧洲多国疫情攀升，北欧多国加强控制

2022-02-12

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

2021年9月8日简报：国内接种新冠疫苗人数达10.95亿人，超21亿剂次，全国高风险区清零；灭活疫苗接种后采用腺病毒载体疫苗加强，效果可能更好；新冠变异病毒mu毒株覆盖美国全境

2022-03-30

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

研究发现腺病毒载体新冠疫苗诱发血栓的机制

2022-02-27

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

专家解读腺病毒载体疫苗：单针接种加快构建免疫屏障

2021-10-25

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

强生疫苗或导致血栓，腺病毒载体疫苗还安全吗？

2022-03-11

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

The Lancet：阿斯利康黑猩猩型腺病毒载体COVID-19疫苗在老年人中诱导了强烈的免疫应答

2021-09-25

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

新冠疫苗前沿知识：mRNA疫苗、重组蛋白疫苗、腺病毒载体疫苗

2021-07-10

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

万泰生物「鼻喷流感病毒载体新冠肺炎疫苗」启动 I 期临床试验

2020-11-07

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

GMP级慢病毒载体制备CAR-T细胞治疗之进展及未来

2021-04-23

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

NEJM: 强生公布腺病毒载体新冠疫苗Ad26.COV2.S早期临床结果，效果惊人

2021-04-30

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

国内首家非病毒载体CAR-T细胞治疗产品获批临床

2019-12-03

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

Emerging Mic Infect：广州生物院研制出新型腺病毒载体埃博拉疫苗

2019-03-06

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

Lancet Child Adol Health：AADC基因腺病毒载体基因治疗用于芳香族氨基酸脱羧酶缺乏

2018-09-03

ewsr12 (审核中...)

前往app查看评论内容

#病毒载体#

N Engl J Med：黑猩猩腺病毒载体埃博拉疫苗

2017-08-22

科室
- - 订阅+
  - 更多科室
工具
服务